Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Federico Montes de Oca"'
Autor:
Karina A. Pasquevich, Lorena M. Coria, Ana Ceballos, Bianca Mazzitelli, Juan Manuel Rodriguez, Agostina Demaría, Celeste Pueblas Castro, Laura Bruno, Lucas Saposnik, Melina Salvatori, Augusto Varese, Soledad González, Veronica V. González Martínez, Jorge Geffner, Diego Álvarez, Laboratorio Pablo Cassará R&D and CMC for ARVAC CG consortium, Ethel Feleder, Karina Halabe, Pablo E. Perez Lera, Federico Montes de Oca, Julio C. Vega, Mónica Lombardo, Gustavo A. Yerino, Juan Fló, Juliana Cassataro
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-12 (2023)
Abstract A Gamma Variant RBD-based aluminum hydroxide adjuvanted vaccine called ARVAC CG was selected for a first in human clinical trial. Healthy male and female participants (18-55 years old) with a complete COVID-19-primary vaccine scheme were ass
Externí odkaz:
https://doaj.org/article/63ec204d1afc426d83ae0e3481ec283a
